Detalhe da pesquisa
1.
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
N Engl J Med
; 368(7): 623-32, 2013 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406027
2.
Radioimmunoscintigraphy and Pretreatment Dosimetry of 131I-Omburtamab for Planning Treatment of Leptomeningeal Disease.
J Nucl Med
; 64(6): 946-950, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759197
3.
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
Thyroid
; 32(3): 273-282, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045748
4.
Optimizing reconstruction parameters for quantitative 124I-PET in the presence of therapeutic doses of 131I.
EJNMMI Phys
; 8(1): 50, 2021 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250566
5.
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
J Clin Endocrinol Metab
; 104(5): 1417-1428, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256977
6.
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.
J Nucl Med
; 60(12): 1794-1801, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31405921
7.
Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.
J Nucl Med
; 48(1): 143-9, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17204711
8.
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
J Nucl Med
; 47(10): 1587-91, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17015892
9.
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
J Nucl Med
; 45(8): 1366-72, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15299063
10.
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
J Nucl Med
; 43(11): 1482-8, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12411552
11.
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
J Nucl Med
; 45(11): 1966-71, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15534070
12.
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
J Nucl Med
; 45(3): 366-73, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15001675
13.
Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays.
Med Phys
; 30(9): 2410-23, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-14528963
14.
A recommendation for revised dose calibrator measurement procedures for 89Zr and 124I.
PLoS One
; 9(9): e106868, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25202987
15.
Quantitative modeling of Cerenkov light production efficiency from medical radionuclides.
PLoS One
; 7(2): e31402, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22363636
16.
Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
J Nucl Med
; 44(7): 1069-71, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12843222
17.
Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
J Nucl Med
; 50(10): 1605-10, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19759114
18.
The Role of Iodine-124-Positron Emission Tomography Imaging in the Management of Patients with Thyroid Cancer.
PET Clin
; 2(3): 313-20, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158012
19.
Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft.
Clin Positron Imaging
; 2(5): 289-296, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14516653
20.
Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer.
Clin Positron Imaging
; 2(3): 173-181, 1999 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14516541